Zacks Research upgraded H.B. Fuller to a "strong-buy" rating following quarterly earnings beats, despite ongoing board disputes with activist investor Ancora over a $1.2 billion proposal.
Ancora Holdings Group reiterated its offer to acquire H.B. Fuller’s Building Adhesive Solutions segment, criticizing the board's rejection and calling for strategic review to unlock shareholder value.
H.B. Fuller announced the closure of its Paducah facility by early 2027, leading to over 100 job losses. Union representatives expressed deep disappointment, citing the decision as a blow to dedicated
Ancora Holding Group proposed acquiring H.B. Fuller’s Building Adhesives Solutions segment for $1.1 to $1.2 billion. H.B. Fuller confirmed the proposal will be evaluated by its Board of Directors.
H.B. Fuller Executive Vice President Nathan Weaver sold approximately $593,000 worth of company stock following option exercises. The transaction occurs amid dividend increases and potential acquisiti
Advanced Medical Solutions Group shareholders approved the sale to H.B. Fuller for £715 million. The acquisition expands H.B. Fuller's medical unit with tissue-healing technologies and targets $55 mil
Activist investor Ancora Holdings has offered $1.1B-$1.2B to acquire H.B. Fuller's Building Adhesive Solutions unit, aiming to pressure the company to reduce debt and focus on higher-margin operations
US investment fund Ancora has proposed acquiring HB Fuller's construction adhesives business for up to EUR 1.1 billion to facilitate strategic refocusing. HB Fuller is currently reviewing the offer bu
Ancora Holdings Group proposed acquiring H.B. Fuller’s Building Adhesive Solutions segment for up to $1.2 billion in cash. This divestiture aims to help H.B. Fuller reduce debt and focus on higher-pri
Activist investor Ancora Holdings Group has offered $1.1 billion to $1.2 billion to acquire H.B. Fuller's building adhesive solutions unit. The move aims to help the company meet deleveraging goals am
Activist investor Ancora is reportedly seeking to acquire H.B. Fuller's adhesives unit, indicating strategic efforts to influence specific business segments within the specialty chemicals industry.
H.B. Fuller will close its Paducah manufacturing site by early 2027, eliminating approximately 100 jobs as part of a strategic reduction of North American facilities.
H.B. Fuller will close its Paducah, Kentucky adhesive plant by early 2027, cutting 100 jobs following a strategic review of its North American manufacturing network.
H.B. Fuller will permanently close its Paducah manufacturing facility by Q1 2027 following a review of its North American network. The company plans to support affected employees with severance and ou
Investors are scrutinizing Nucor, LyondellBasell, and H.B. Fuller ahead of Q2 2026 earnings as these companies lead materials-sector earnings revisions amid economic uncertainties.
H.B. Fuller has launched a recommended cash offer to acquire Advanced Medical Solutions Group, aiming to expand its medical adhesives portfolio and market presence. The deal combines AMS's surgical ad
H.B. Fuller agreed to acquire a U.K. medical products firm for $870 million, countering a competing bid from Ancora. This strategic move expands H.B. Fuller's portfolio into the medical sector through
HB Fuller proposed a £715m takeover of Advanced Medical Solutions to expand its medical portfolio, including wound care and adhesives, expected to add $300m in annual revenue.
H.B. Fuller shares declined following its announcement of a £715 million all-cash acquisition of Advanced Medical Solutions. Investors expressed concern over execution risks and balance sheet strain d
AMS has mandated that H.B. Fuller must declare a firm intention to make an offer for the company by July 2, 2026. This announcement signals significant corporate activity regarding a potential acquisi
UBS raised its price target for specialty adhesives firm H.B. Fuller to $71 while maintaining a Neutral rating. The move comes as activist investor Ancora Holdings urges a review of strategic alternat
Norges Bank initiated a new position in H.B. Fuller, acquiring 743,407 shares valued at approximately $44.2 million. The company recently reported Q1 earnings that slightly exceeded estimates and incr
Ancora Holdings opposes H.B. Fuller's $800M acquisition of Advanced Medical Solutions, citing reckless spending during debt reduction efforts. The activist investor demands a strategic alternatives re
Activist investor Ancora Holdings urges HB Fuller to withdraw its acquisition bid for UK-based AMS, citing poor timing and strategic misalignment. Instead, Ancora recommends focusing on share repurcha
H.B. Fuller invested in VerdaFresh oxygen barrier technology to enable mono-material packaging structures. The solution eliminates non-recyclable layers, supporting sustainability goals while streamli
Activist investor Ancora urges H.B. Fuller to abandon acquiring Advanced Medical Solutions Group, citing leverage risks and threatening a proxy contest if the board does not initiate a strategic revie
Activist investor Ancora is pressuring adhesives manufacturer H.B. Fuller to withdraw its bid for a U.K. company, signaling increased scrutiny on corporate acquisitions.
Activist investor Ancora Holdings urges H.B. Fuller to abandon its proposed acquisition of Advanced Medical Solutions Group. The investor calls for a strategic review of H.B. Fuller, including potenti
ChemBrief